Provided by Tiger Trade Technology Pte. Ltd.

Novavax

11.01
-0.2100-1.87%
Post-market: 11.040.0300+0.27%16:47 EDT
Volume:6.20M
Turnover:67.86M
Market Cap:1.81B
PE:-7.25
High:11.18
Open:11.01
Low:10.76
Close:11.22
52wk High:13.39
52wk Low:6.20
Shares:164.43M
Float Shares:143.00M
Volume Ratio:0.49
T/O Rate:4.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5181
EPS(LYR):2.58
ROE:-898.20%
ROA:-6.51%
PB:-9.49
PE(LYR):4.27

Loading ...

What's Going On With Novavax Stock On Friday?

Benzinga
·
May 09

Novavax Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
May 08

Novavax to present at BofA Securities 2026 Health Care Conference

Reuters
·
May 08

Stock Track | Novavax Soars 5.02% in Pre-Market After TD Cowen Raises Price Target

Stock Track
·
May 07

Novavax Inc. Stock Climbs 15.6%, Outperforms Peers

Dow Jones
·
May 07

Novavax Is Maintained at Hold by TD Cowen

Dow Jones
·
May 07

Why Novavax Stock Is Trading Higher On Wednesday?

Benzinga Earnings
·
May 07

Stock Track | Novavax Soars 17.35% Intraday After Beating Q1 Revenue Estimates on Vaccine Deals Strength

Stock Track
·
May 07

Novavax Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 06

Novavax Shares up 9% After Q1 Revenue Above Expectations

THOMSON REUTERS
·
May 06

BUZZ-U.S. STOCKS ON THE MOVE-Walt Disney, CVS, Uber

Reuters
·
May 06

Earnings Flash (NVAX) Novavax Posts Q1 Net Loss $0.06 a Share, vs. FactSet Est of $0.24 Loss

MT Newswires Live
·
May 06

Novavax Reports First Quarter 2026 Financial Results and Operational Highlights

THOMSON REUTERS
·
May 06

Novavax Outlook FY Adjusted Total Revenue USD 230-270 Million

THOMSON REUTERS
·
May 06

Novavax Inc FY2026 REV View $400.3 Mln -- Lseg Ibes Data

THOMSON REUTERS
·
May 06

Novavax: Reiterates 2026 Revenue Framework, Combined R&D & SG&a Expense Guidance

THOMSON REUTERS
·
May 06

Novavax Shares Gain 6.2% Premarket After Q1 Revenue Above Expectations

THOMSON REUTERS
·
May 06

Novavax beats first-quarter revenue estimates on vaccine deals strength

Reuters
·
May 06

Novavax Inc - Q1 2026 Total Revenue $139.5 Mln - SEC Filing

THOMSON REUTERS
·
May 06

Novavax Inc - Q1 2026 Basic EPS $-0.06 VS $3.22; Diluted EPS $-0.06 VS $2.93 in Q1 2025 - SEC Filing

THOMSON REUTERS
·
May 06